Cryotherapy and Body Slimming
关键词
抽象
描述
Prospective, monocentric pilot and comparative (before and after) study in simple blind (assessor different from the operator).
- The effectiveness of cryotherapy will be evaluated by the metric measurement of the treated areas: waist circumference, from the hips to the level of the saddlebags.
- Measurement of subcutaneous fat mass with iDXA scanner on treated areas
- Metabolic parameters from a blood test: Liver function (AST, ALT, gamma GT), inflammatory markers, plasmatic fatty acids, glycerol, total cholesterol, triglycerides, lipids, blood sugar, insulin, lactate.
日期
最后验证: | 01/31/2020 |
首次提交: | 02/23/2020 |
提交的预估入学人数: | 02/24/2020 |
首次发布: | 02/26/2020 |
上次提交的更新: | 02/24/2020 |
最近更新发布: | 02/26/2020 |
实际学习开始日期: | 09/16/2017 |
预计主要完成日期: | 04/21/2018 |
预计完成日期: | 09/16/2018 |
状况或疾病
干预/治疗
Device: Croytherapy on abdomen and saddlebags
相
手臂组
臂 | 干预/治疗 |
---|---|
Experimental: Croytherapy on abdomen and saddlebags Six (6) to 10 applicators (application area of 17 cm X 6 cm) are applied on the dorsal side (back, waist, saddlebags) for 45 minutes and then on the ventral side (belly) for 45 minutes, with adjustments according to the size of the participant. The temperature applied with the device is variable (-10°c to -7°C). | Device: Croytherapy on abdomen and saddlebags Application of variable temperature (-10°c to -7°c) on the treated areas using the cryotherapy device FG660L-006 (Beijing ADSS Development CO., Ltd) |
资格标准
有资格学习的年龄 | 18 Years 至 18 Years |
有资格学习的性别 | Female |
接受健康志愿者 | 是 |
标准 | Inclusion Criteria: - Patients ≥ 18 years old and non-menopausal with a BMI between 20 and 30 (20≥IMC≤30), with an overload of abdominal subcutaneous fat tissue and at the saddlebags Exclusion Criteria: - - < 18 years old. - Pregnancy - Breastfeeding - Cold allergy: 2-minute ice cube test positive - A waist/hip ratio indicative of a pathological fat distribution (>0.8 for women, >0.9 for men) - Endocrine pathologies (Cushing's disease, endocrine tumours, unbalanced frank or labile hypothyroidism, hirsutism and hyper-androgenism, insulin resistance and/or unbalanced type 2 diabetes...) - Neoplasia - Psychiatric pathologies with or without treatment (Antidepressants, Neuroleptics, Anxiolytics...), well characterized anorexia-bulimia syndromes. - Established alcoholism. Daily alcohol consumption should not exceed 2 glasses of wine per day. - Digestive pathologies (especially hepatic) and functional digestive disorders (chronic constipation, alternating constipation-diarrhoea, chronic abdominal pain). - Weaknesses of the abdominal wall (umbilical, inguinal, crural hernias) - HIV in therapy - Genetic deformities and diseases - Vegetarian/vegetarian diet, macrobiotic diet - Spasmophilia - Surgery less than 3 months old - Unbalanced coronary artery disease, untreated angina |
结果
主要结果指标
1. Metric measurements of the treated areas (cm) [15 days after treatment]
2. Metric measurements of the treated areas (cm) [3 months after treatment]
次要成果指标
1. iDXA scanner measurement [15 days]
2. iDXA scanner measurement [3 months]
3. Metabolic assessment [15 days after treatment]
4. Metabolic assessment [15 days after treatment]
5. Metabolic assessment [15 days after treatment]
6. Metabolic assessment [15 days after treatment]
7. Metabolic assessment [15 days after treatment]